WEREWOLF THERAPEUTICS, INC.
Profile
Company Names
WEREWOLF THERAPEUTICS, INC.
Addresses
1030 MASSACHUSETTS AVENUE, SUITE 210, CAMBRIDGE, MA 02138
Phone Numbers
617-952-0555
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2017
State Incorporated:
DELAWARE
Total Amount Raised:
$128,242,596.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-12-23
$72,069,999.00
$72,069,999.00
$0.00
Equity
1
2019-08-02
$56,172,597.00
$56,172,597.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
SAKAE
ASANUMA
DIRECTOR
DAVID
CORDO
EXECUTIVE OFFICER
DEREK
DIROCCO
DIRECTOR
LUKE
EVNIN
DIRECTOR
ENTEROMEDICS INC
| MPM BIOVENTURES V, L.P.
| COSTIM PHARMACEUTICALS INC.
| AMPHIVENA THERAPEUTICS, INC.
| POTENZA THERAPEUTICS, INC.
| VESUVIUS PHARMACEUTICALS, INC.
| ONCORUS, INC.
| BLADE THERAPEUTICS, INC.
| DIGITX PARTNERS LLC
| TRIEZA THERAPEUTICS, INC.
| MAVERICK THERAPEUTICS INC.
| HARPOON THERAPEUTICS, INC.
| TWENTYEIGHT-SEVEN, INC.
| MPM ONCOLOGY INNOVATIONS FUND LP
| FRONTIER MEDICINES CORP
| WEREWOLF THERAPEUTICS, INC.
| UMOJA BIOPHARMA, INC.
| REDONA THERAPEUTICS, INC.
DANIEL
HICKLIN
EXECUTIVE OFFICER, DIRECTOR
ALON
LAZARUS
DIRECTOR
BRIGGS
MORRISON
DIRECTOR
CHRISTOPH
WESTPHAL
DIRECTOR
VERASTEM, INC.
| OVASCIENCE, INC.
| FLEX PHARMA, INC.
| RECROS MEDICA, INC.
| PYXIS ONCOLOGY, INC.
| TSCAN THERAPEUTICS, INC.
| WEREWOLF THERAPEUTICS, INC.
| LONGWOOD FUND V, L.P.
| IMMUNEID, INC.
| IMMUNITAS THERAPEUTICS, INC.
| LONGWOOD FUND VI, L.P.
| LONGWOOD SPECIAL SITUATIONS FUND, L.P.
| NEWLEOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

